CNBC's Kate Kelly reports on the activist investor who grabbed a stake in Buffalo Wild Wings. And Marcato buys 5.5 million Terex shares.
Alex Zukin, Piper Jaffray, discusses the stage we are at with the cloud.
Even if the Russian email hacking story dies down by Friday, Trump will have his Twitter account ready to stir the pot, says Jake Novak.
Avenue Capital Group CEO Marc Lasry weighs in on the markets and economy, at the Democratic National Convention in Philadelphia.
The equal-weighted S&P 500 is outperforming the market, what does this mean for stocks?
Gold markets were mixed after the Fed stopped short of indicating that a further increase in interest rates is on the cards for this year.
A daily morning look at the financial stories you need to know to start the day.
The Federal Reserve should have started raising interest rates a long time ago, experts said Wednesday.
Evercore's Ralph Schlosstein comments on merger activity, as well as Wall Street and the general election.
CNBC's Meg Tirrell reports on a promising new treatment for hemophilia by Biomarin. And Kadmon has a tough first day of trading.
Discussing the market reaction to the Fed decision to leave rates unchanged, with Joe Zock, Tocqueville Asset Management, Stephen Guilfoyle, Stuart Frankel; Rick Rieder, BlackRock; and CNBC's Rick Santelli.
If you wondered how Trump would steal the headlines back from Hillary Clinton this week, now you know: Russian hackers and Hillary’s email. And the Dems fell for it, says Jake Novak.
The DNC has an all-star lineup of speakers tonight, including VP nominee Tim Kaine, current VP Joe Biden and President Obama. Also, Trump's call to spy on Hillary Clinton.
CNBC's Steve Liesman reports on the latest data behind the Fed decision to keep rates unchanged.
Earnings expectations for Facebook and a pop for Apple after its earnings announcement, with CNBC's Dom Chu.
A economy needs positive interest rates in order to function normally, Janus Capital's Bill Gross says.
Victor Anthony, Axiom Capital, and Ali Mogharabi, Morningstar, look ahead to Facebook's earnings announcement this afternoon.
The FTC has approved Teva's acquisition of an Allergan unit. And drug developer Kadmon sinks on its first day as a publicly-traded company. And a breakthrough in ALS research? CNBC's Meg Tirrell reports.
Sen. Christopher Coons (D-Delaware) responds to Donald Trump's challenge to Russian hackers to dredge up Hillary Clinton's emails.
Milo Yiannopoulos, Breitbart News, discusses his ban from Twitter and his coverage of the Bernie supporters at the DNC in Philadelphia.